Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Other Operating Expenses (2023 - 2025)

Kezar Life Sciences (KZR) has disclosed Other Operating Expenses for 3 consecutive years, with $6.8 million as the latest value for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 57075.0% year-over-year to $6.8 million; the TTM value through Dec 2025 reached $6.8 million, up 365.1%, while the annual FY2025 figure was $6.8 million, 365.1% up from the prior year.
  • Other Operating Expenses hit $6.8 million in Q4 2025 for Kezar Life Sciences, up from -$12000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $6.8 million in Q4 2025 and bottomed at -$12000.0 in Q4 2024.
  • Average Other Operating Expenses over 3 years is $3.6 million, with a median of $3.8 million recorded in 2023.
  • Year-over-year, Other Operating Expenses plummeted 100.19% in 2024 and then soared 57075.0% in 2025.
  • Kezar Life Sciences' Other Operating Expenses stood at $6.2 million in 2023, then crashed by 100.19% to -$12000.0 in 2024, then skyrocketed by 57075.0% to $6.8 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $6.8 million, -$12000.0, and $1.5 million for Q4 2025, Q4 2024, and Q2 2024 respectively.